Dr Lam William Thanadabout, MD | |
1400 N 500 E, Logan, UT 84341-2455 | |
(435) 752-0422 | |
Not Available |
Full Name | Dr Lam William Thanadabout |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 22 Years |
Location | 1400 N 500 E, Logan, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649236316 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 6990986-8017 (Utah) | Secondary |
208M00000X | Hospitalist | 6990986-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Logan Regional Hospital | Logan, UT | Hospital |
Logan Regional Hospital Transitional Care Unit | Logan, UT | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Many Black men suffer symptoms of traumatic stress in the aftermath of traumatic injury, and they also often carry social concerns, including experiences of discrimination and stigma.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Genta Incorporated has announced the release of final results from the Company's Phase 1 clinical trial of G4544, a proprietary small molecule that is intended as a treatment for diseases associated with accelerated bone loss. Results showed that the drug was very well-tolerated, and that blood levels were achieved in a range that is known to be clinically bioactive. The data were featured in a poster session at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago on Saturday, May 31, 2008.
In a demonstration of the power of green chemistry, scientists are reporting development of a new and more efficient process for making one of the most costly and widely used medications for severe mental illness.
› Verified 2 days ago
Entity Name | Ihc Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Many Black men suffer symptoms of traumatic stress in the aftermath of traumatic injury, and they also often carry social concerns, including experiences of discrimination and stigma.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Genta Incorporated has announced the release of final results from the Company's Phase 1 clinical trial of G4544, a proprietary small molecule that is intended as a treatment for diseases associated with accelerated bone loss. Results showed that the drug was very well-tolerated, and that blood levels were achieved in a range that is known to be clinically bioactive. The data were featured in a poster session at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago on Saturday, May 31, 2008.
In a demonstration of the power of green chemistry, scientists are reporting development of a new and more efficient process for making one of the most costly and widely used medications for severe mental illness.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lam William Thanadabout, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (435) 752-0422 | Dr Lam William Thanadabout, MD 1400 N 500 E, Logan, UT 84341-2455 Ph: (435) 752-0422 |
News Archive
Many Black men suffer symptoms of traumatic stress in the aftermath of traumatic injury, and they also often carry social concerns, including experiences of discrimination and stigma.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Genta Incorporated has announced the release of final results from the Company's Phase 1 clinical trial of G4544, a proprietary small molecule that is intended as a treatment for diseases associated with accelerated bone loss. Results showed that the drug was very well-tolerated, and that blood levels were achieved in a range that is known to be clinically bioactive. The data were featured in a poster session at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago on Saturday, May 31, 2008.
In a demonstration of the power of green chemistry, scientists are reporting development of a new and more efficient process for making one of the most costly and widely used medications for severe mental illness.
› Verified 2 days ago
Eric Snelson, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1400 N 500 E, Logan, UT 84341 Phone: 435-716-1000 |